Health Catalyst (HCAT) Preferred Stock Liabilities (2018 - 2019)
Health Catalyst posted quarterly Preferred Stock Liabilities of $584.6 million for Q2 2019, up 69.32% year-on-year from $345.2 million in Q2 2018, and up 20.3% on a QoQ basis from $485.9 million in Q1 2019.
Health Catalyst (HCAT) has 2 years of Preferred Stock Liabilities data on file, last reported at $584.6 million in Q2 2019.
- For the quarter ending Q2 2019, Preferred Stock Liabilities rose 69.32% year-over-year to $584.6 million; the trailing twelve-month figure through Jun 2019 stood at $584.6 million (up 69.32% YoY), and the FY2018 full-year result was $409.8 million, up 27.45% from the prior year.
- Preferred Stock Liabilities for Q2 2019 stood at $584.6 million, up from $485.9 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $584.6 million in Q2 2019 and bottomed at $345.2 million in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 199.87 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Health Catalyst | 98.36 Mn | -10.46 Mn | 35.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 584.57 Mn |
| Mar 31, 2019 | 485.93 Mn |
| Dec 31, 2018 | 409.85 Mn |
| Sep 30, 2018 | 345.76 Mn |
| Jun 30, 2018 | 345.25 Mn |